Search clinical trials for: GNR-060

Total 2999 results

AO GENERIUM

Enrolling by invitation

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

Idiopathic Thrombocytopenic Purpura

Russian Federation
AO GENERIUM

Completed

Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP

Idiopathic Thrombocytopenic Purpura

Russian Federation
AO GENERIUM

Recruiting

Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction

ST Elevation Myocardial Infarction

Russian Federation
AO GENERIUM

Recruiting

GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL

ALL | B-precursor Acute Lymphoblastic Leukemia | GNR-084

Russian Federation
AO GENERIUM

Recruiting

A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II

Metabolic Diseases | Mucopolysaccharidosis Type II

Russian Federation
AO GENERIUM

Completed

A Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers

Metabolic Diseases | Mucopolysaccharidosis Type II

Russian Federation
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants

HIV Infections

United States, Puerto Rico, Zimbabwe, South Africa
AO GENERIUM

Recruiting

Efficacy, Safety, pharmacokinetiсs, Immunogenicity of GNR-067 and Lucentis® (NAP)

Age Related Macular Degeneration (ARMD)

Russian Federation
AO GENERIUM

Completed

Safety and Pharmacokinetics of GNR-038 in Healthy Volunteers

Hereditary Angioedema

Russian Federation
Bristol-Myers Squibb

Withdrawn

MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma

Lymphoma, Large-Cell

United States, France
Dr. Reddy's Laboratories Limited

Completed

A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)

Psoriasis

United States
Pieris Australia Pty Ltd

Completed

Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects With Mild Asthma

Asthma

Australia
Pieris Australia Pty Ltd

Completed

Study of a Single Dose of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy Subjects

Healthy Subjects

Australia
AO GENERIUM

Active, not recruiting

A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies

Melanoma | Carcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung

Russian Federation
Boryung Pharmaceutical Co., Ltd
Covance

Completed

Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects

Essential Hypertension
DermaGen AB

Completed

A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060

Atopic Dermatitis

Sweden
University of Surrey
Medical University of Graz; KU Leuven; University of Cambridge; UK Civil Aviation... and other collaborators

Recruiting

Safe Use of New Technologies in Diabetes in Flight (SUNDIF)

Type1 Diabetes

United Kingdom
St. Justine's Hospital

Terminated

Effect of Global Postural Re-education in Idiopathic Scoliosis

Idiopathic Scoliosis

Canada
The Dental Hospital of Zhejiang University School...

Recruiting

Radiographic Bone Volume Alteration After Jaw Cyst Enucleation With Different Bone Grafts

Jaw Cysts

China
Universidad Autonoma de Ciudad Juarez

Completed

Physiological Effect of Ataulfo Mango (Manguifera Indica) Beverage in Exercise

Exercise-induced Oxidative Stress
Pfizer

Completed

Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors

Neoplasms | Carcinoma | Cancer | Advanced Solid Tumors | Malignancy

United States
DermaGen AB
Pergamum AB

Completed

A Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis

Acute Otitis Externa

Sweden
University of Alabama at Birmingham

Not yet recruiting

Evaluation of Free Gingival Graft Timing

Ridge Augmentation | Alveolar Mucosa

United States
Antengene Corporation

Active, not recruiting

A Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (SEARCH)

Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

China
Medtronic BRC
Vitatron GmbH

Unknown

Ventricular Pacing Site Selection (V-PASS)

Atrioventricular Block

Germany
Medical University of Warsaw

Unknown

Clinical and Radiographic Evaluation of Guided Tissue Regeneration With Radiation-sterilized Allogenic Bone Grafts or Xenogenic Grafts for the Treatment of Intrabony Defects in Aggressive Periodontitis

Periodontitis, Aggressive

Poland
Gunkang Pharmaceuticals, Inc

Recruiting

Clinical Study to Evaluate the Efficacy and Safety of GNS-212-E in Bowel Preparation for Colonoscopy (GNS-212-E)

Colonoscopy | Bowel Preparation

Korea, Republic of
Pfizer

Withdrawn

A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma

Glioblastoma
University of the State of Santa Catarina

Completed

Effects of Global Postural re-Education Program

Healthy | Elderly

Brazil
University of Colorado, Denver

Completed

Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease

Liver Disease

United States
Sichuan Baili Pharmaceutical Co., Ltd.
SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

Recruiting

A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL

Non-Hodgkin Lymphoma | NK/T Cell Lymphoma | Vascular Immunomother T Cell Lymphoma

China
AstraZeneca

Completed

Study to Assess Effect of Device and Formulation on Pharmacokinetics (PK) of AZD1402

Asthma

United Kingdom
University of South Florida

Completed

Enhanced Pharmacist-Managed Anticoagulation Service in a University-based Family Medicine Clinic

Anticoagulation | Home INR Monitoring
AbbVie
Boehringer Ingelheim

Completed

A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease

Crohn Disease

United States, Belgium, Canada, Germany, Korea, Republic of, Netherlands, Poland, Spain, United Kingdom
UCB Celltech
Parexel; Comac Medical; MAC Clinical Research; ARENSIA, Moldova

Completed

Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis

Psoriatic Arthritis

Bulgaria, Moldova, Republic of, United Kingdom
University of Alabama at Birmingham
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia

Sickle Cell Disease | Glomerular Disease | Renal Disease

United States
University Reproductive Associates

Recruiting

GnRH for Luteal Support in IVF/ICSI/FET Cycles

Infertility

United States
University of North Carolina, Chapel Hill
North Carolina Translational and Clinical Sciences Institute

Completed

Multidrug Resistant Gram-negative Bacilli Colonization and Infection in Burn

Multi-drug Resistant Gram-negative Bacilli Colonization

United States
National and Kapodistrian University of Athens
Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa... and other collaborators

Not yet recruiting

Ovarian Stimulation With FSH Alone Versus FSH Plus GnRH Antagonist in an Oocyte Donor/Recipient Programme

Premature Luteinisation | Progesterone Elevation
AGC Biologics S.p.A.

Completed

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma (NGR010)

Malignant Pleural Mesothelioma

Italy
AGC Biologics S.p.A.

Completed

Study of NGR-hTNF Administered at High Doses in Patient With Advanced or Metastatic Solid Tumour

Solid Tumors

Italy
AGC Biologics S.p.A.

Completed

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

Italy
Glostrup University Hospital, Copenhagen
University of Copenhagen

Completed

-Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans.

Type 2 Diabetes

Denmark
Taipei Medical University Hospital

Completed

Preoperative Renal Insufficiency Predicts Postoperative Adverse Outcomes

Renal Insufficiency | Morality

Taiwan
Manchester University NHS Foundation Trust
University of Manchester

Completed

BOne Dysfunction in Donor NEphrectomieS (BONES)

Renal Failure | Kidney Donors

United Kingdom
University Magna Graecia

Completed

CA 125 and VAS Pain Score Changes to Diagnose Endometriosis

Endometriosis | Pelvic Pain

Italy
Istituto Clinico Humanitas

Completed

RESCUE PROTOCOL AND FRESH EMBRYO TRANSFER

GnRH Trigger and Rescue Protocol
CicloMed LLC
Cmed Clinical Services

Completed

Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
Glenmark Pharmaceuticals Ltd. India
Glenmark Pharmaceuticals S.A.

Completed

Safety and Tolerability of GBR 900 in a Single Ascending Dose Study in Healthy Subjects

Healthy

United Kingdom
Doug Parkerson
United States Agency for International Development (USAID); AVSI Foundation

Completed

Impact of Graduating to Resilience on Child Development in Uganda

Child Development

Uganda

Search clinical trials for: GNR-060

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations